Prognostic implication of trisomy 12 and non-trisomy 12 karyotypes in B cell chronic lymphocytic leukemia

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Human pathology·1992

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Cancer genetics and cytogenetics·1992

Application of fluorescence in situ hybridization in hematological disorders.

Cancer genetics and cytogenetics·1992

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Cancer genetics and cytogenetics·1992

Isolation of a yeast artificial chromosome clone that spans the (12;16) translocation breakpoint characteristic of myxoid liposarcoma.

Cancer genetics and cytogenetics·1992

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

Cancer genetics and cytogenetics·1992

The origins of rare glycosylphosphatidylinositol-deficient cells in normal and immune-mediated hematopoiesis.

Blood·2026

How I Treat Heavy Menstrual Bleeding in Patients with Bleeding Disorder of Unknown Cause.

Blood·2026

Choice of a different donor reduces relapse risk after second allogeneic SCT for MDS.

Blood·2026

A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma.

Blood·2026

EVIDENCE OF CLL DEVELOPMENT FROM HEMATOPOIETIC PROGENITOR CELLS IN HUMANS.

Blood·2026

Telomere length in chronic lymphocytic leukemia treated with venetoclax-based regimen in GAIA/CLL13 and CLL2-GIVe trials.

Blood·2026

Exploring the Expanding Role of Nuclear Receptor LRH-1/NR5A2 in Cell Biology and Immunity.

International journal of cell biology·2026

Cuproptosis-related molecular alterations in a neonatal rat model of hypoxic-ischemic brain damage.

Frontiers in neurology·2026

Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL.

Research square·2026

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors.

bioRxiv : the preprint server for biology·2026

Myeloid differentiation-associated autophagy drives venetoclax resistance in AML.

Research square·2026

Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator.

Research square·2026

Related Experiment Videos

Prognostic implication of trisomy 12 and non-trisomy 12 karyotypes in B cell chronic lymphocytic leukemia

Related Concept Videos

Cytogenetic and pathologic aspects of Ewing's sarcoma and neuroectodermal tumors.

Cytogenetic and fluorescence in situ hybridization analysis of breast fibroadenomas.

Application of fluorescence in situ hybridization in hematological disorders.

Cytogenetic and molecular studies of a familial renal cell carcinoma.

Isolation of a yeast artificial chromosome clone that spans the (12;16) translocation breakpoint characteristic of myxoid liposarcoma.

Cytogenetic and FISH studies of abnormal X chromosomes in a patient with ANLL.

The origins of rare glycosylphosphatidylinositol-deficient cells in normal and immune-mediated hematopoiesis.

How I Treat Heavy Menstrual Bleeding in Patients with Bleeding Disorder of Unknown Cause.

Choice of a different donor reduces relapse risk after second allogeneic SCT for MDS.

A multicenter phase II study of glofitamab plus polatuzumab-R-CHP for patients with diffuse large B-cell lymphoma.

EVIDENCE OF CLL DEVELOPMENT FROM HEMATOPOIETIC PROGENITOR CELLS IN HUMANS.

Telomere length in chronic lymphocytic leukemia treated with venetoclax-based regimen in GAIA/CLL13 and CLL2-GIVe trials.

Exploring the Expanding Role of Nuclear Receptor LRH-1/NR5A2 in Cell Biology and Immunity.

Cuproptosis-related molecular alterations in a neonatal rat model of hypoxic-ischemic brain damage.

Off-Target MAP2K7 Inhibition Drives the Antileukemic Activity of the PD-1/PD-L1 inhibitor ACS-69 in Pediatric T-ALL.

A CRISPR-Cas9 platform for primary human hepatocytes enables arrayed screening and in vivo validation of HBV host factors.

Myeloid differentiation-associated autophagy drives venetoclax resistance in AML.

Structure of full-length APOBEC3B bound to EBV BORF2 reveals coordinated neutralization of a cancer-associated mutator.

Related Experiment Videos

Prognostic implication of trisomy 12 and non-trisomy 12 karyotypes in B cell chronic lymphocytic leukemia

Related Concept Videos

Related Articles